Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
A pedestrian wearing a hooded jacket has been killed by a commuter train in Dallas.
The woman walked into a Trinity Railway Express train, which links Dallas and Fort Worth and carries about 10,000 passengers daily, during afternoon rush hour Monday.
Three years ago, Dr.Nissen, a cardiologist at the Cleveland Clinic, conducted a landmark study that suggested that the best-selling diabetes drug Avandia raised the risk of heart attacks. The study led to a Congressional inquiry, stringent safety warnings, a sharp drop in the drug’s sales of GlaxoSmithKline, Avandia’s maker.
The battle between Dr. Nissen and GlaxoSmithKline was waged from afar in news releases and published papers. But on May 10, 2007, 11 days before Dr. Nissen’s study was published in The New England Journal of Medicine, he and four company executives met face to face in a private meeting whose details have not been disclosed until now.
The maker of Poligrip denture cream will stop making formulas containing zinc amid lawsuits claiming years of excessive use caused neurological damage and blood problems in consumers, allegedly crippling some.
GlaxoSmithKline will stop making and marketing Super Poligrip Original, Ultra Fresh and Extra Care products in the U.S. The company plans to reformulate the creams without zinc.
Confidential studies by Food and Drug Administration officials recommend that GlaxoSmithKline’s Avandia, a diabetes medicine, get pulled from the market because it is linked to heart attacks.
The studies, released as part of a report on Avandia by staff of Senate Finance Committee members Chuck Grassley (R., Iowa) and Max Baucus (D., Mont.), also say any head-to-head trial where patients get Avandia and Takeda Pharmaceutical Co.’s diabetes medicine Actos would be “unethical and exploitative.” GlaxoSmithKline is currently sponsoring a study, called TIDE, where patients get either Avandia, Actos or other medicines.
Hundreds of people taking Avandia, a diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market.
The reports, obtained by The New York Times, say that if every diabetic now taking Avandia were instead given a similar pill named Actos, about 500 heart attacks and 300 cases of heart failure would be averted every month because Avandia can hurt the heart. Avandia, intended to treat Type 2 diabetes, is known as rosiglitazone and was linked to 304 deaths during the third quarter of 2009.
A range of health problems are linked to the pits on military bases in Iraq and Afghanistan. Toxic substances have been found in the smoke.
The noxious smoke plumes that wafted over the military base in Balad, Iraq, alarmed Lt. Col. Michelle Franco. The stench from a huge burn pit clung to her clothing, skin and hair.
She wheezed and coughed constantly. When Franco returned to the U.S., she was diagnosed with reactive airway dysfunction syndrome. She is no longer able to serve as an Air Force nurse.
The jury ordered pain pump manufacturer I-Flow Corp. to pay $4.5 million to a man whose implanted pump caused the cartilage in his shoulder joint to wear almost completely away, a condition known as chondrolysis.
In the first verdict of its kind, an Oregon jury has found for the plaintiff in a case against the manufacturer of a pain pump, awarding $4.5 million to a man for permanent damage to his shoulder joint. The verdict, which included damages paid to his wife for loss of consortium, comes in what many considered a test case for the defense. (Beale v. I-Flow Corp., No. 080101554 (Or., Multnomah Co. Dist. Jan. 22, 2010).)
Read full story here Trial
Toyota Motor Corp. and U.S. regulators are looking into possible steering problems in the company’s popular Corolla compact, the latest quality issue to surface in the wake of two recalls that covered millions of vehicles and forced Toyota to halt U.S. sales of eight models.
The Corolla investigation could start as early as Thursday, said a U.S. Transportation Department official. The inquiry will cover about 500,000 model-year 2009 and 2010 Corollas, officials said.
The National Highway Traffic Safety Administration has received 163 complaints about the steering in Corollas from those model years, according to the safety agency’s Web site.
U.S. regulators on Tuesday opened an investigation into whether Toyota Motor Corp acted in a timely way to recall cars for acceleration problems, and the automaker moved to slow its U.S. production to avoid a costly ballooning of inventories.
The National Highway Traffic Safety Administration said it had requested production data, consumer complaints and other documents expected to shed light on how and when Toyota learned of problems affecting about 6 million vehicles it has recalled in the United States.
Roche Holding AG, the Swiss drugmaker, must pay $25.16 million in damages to a former user of its Accutane drug who blamed the acne medicine for his inflammatory bowel disease, a New Jersey jury ruled.
Andrew McCarrell, 38, won the verdict at a retrial in Atlantic City, New Jersey. An appeals court ordered the new trial after overturning a $2.62 million award he won in May 2007. McCarrell, a computer technician from Birmingham, Alabama, testified he got sick after taking the drug for acne in 1995. He needed five surgeries, including one to remove his colon.
Dallas Fort Worth Injury Lawyer Blog